Sinopharm Group Co. Ltd. (01099.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenHKD 15.05

From 52W high−31.60%

Volume7.48M

Market capHKD 46.87B

P/E (TTM)5.7x

P/S (TTM)0.1x

Div yield5.26%

Key dataSep 18, 2026

Open

HKD 15.05

From 52W high

−31.60%

Volume

7.48M

Market cap

HKD 46.87B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

7.9x

P/E (TTM)

5.7x

RSI (14)

30.2

MomentumView details →

1D Return

−0.07%

YTD Return

−22.74%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

5.7x

EV/EBITDA

7.9x

EV/Sales

0.3x

P/S (TTM)

0.1x

P/B (TTM)

0.5x

ProfitabilityView details →

Gross Margin

7.03%

Net Margin

1.24%

EBITDA Margin

3.62%

ROE (TTM)

8.27%

ROA (TTM)

1.74%

Asset Turnover

1.43x

GrowthView details →

Revenue YoY

−1.36%

EPS YoY

+3.21%

FCF YoY

+177.46%

Revenue CAGR 3Y

+1.37%

EPS CAGR 3Y

−5.69%

EBITDA YoY

−0.04%

MomentumView details →

1D Return

−0.07%

YTD Return

−22.74%

1Y Return

−18.33%

RSI (14)

30.2

vs 50D SMA

−8.96%

vs 200D SMA

−19.74%

Capital & dividendView details →

Debt/Equity

1.34x

Current Ratio

1.40x

Quick Ratio

1.14x

Div Yield

5.26%

Div Rate

HKD 0.79

Div Growth 1Y

+6.90%

EarningsView details →

EPS (Actual)

HKD 1.26

EPS Surprise

0.00%

Beats (12Q)

0/12

Next Q EPS Est

—

Avg Surprise (4Q)

0.00%

Rev Surprise

−0.81%

Financials snapshotView financials →

Revenue (TTM)

1.14T

Net Income (TTM)

13.85B

Op. CF (TTM)

64.59B

Next earningsMar 19, 2027 →

Latest newsMore news →

Sinopharm Group and Hansoh Pharmaceutical reached a strategic cooperation agreement, covering broad market, medical access, retail, and DTP special cooperation agreements, upgrading their collaboration to full-chain, full-cycle strategic coordination.12d ago

Similar companies

Cardinal Health, Inc.CAH Shanghai Pharmaceuticals Holding Co., Ltd02607.HK Cencora, Inc.COR XD上海医601607.SH 九州通600998.SH McKesson CorporationMCK Find similar companies →

Latest newsMore news →

Sinopharm Group and Hansoh Pharmaceutical reached a strategic cooperation agreement, covering broad market, medical access, retail, and DTP special cooperation agreements, upgrading their collaboration to full-chain, full-cycle strategic coordination.12d ago